Pfizer Stock Price Before Q3 Earnings: Patents and Pipeline
Pfizer’s three largest patent-exposed drugs brought in about $4 billion in the second quarter alone. Within roughly 18 months, generic versions of all three are due to reach the US market. The Pfizer stock price traded near $29.91 on October 29, up about 21% this year. In other words, investors are paying more for a […] The post Pfizer Stock Price Before Q3 Earnings: Patents and Pipeline…
Read at Trade The PoolThe source’s licence allows a summary here, not the full story.Not investment advice. This article is for information only. Prices are as of publication; trader data is aggregated, anonymised and delayed 15 minutes.